View in EDS HTML Full Text PDF Full Text

A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer.

Saved in:
Bibliographic Details
Title: A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer.
Authors: van Veggel, Bianca A. M. H.1 (AUTHOR), van der Wekken, Anthonie J.2 (AUTHOR), Paats, Marthe S.3 (AUTHOR), Hendriks, Lizza E. L.4 (AUTHOR), Hashemi, Sayed M. S.5 (AUTHOR), Daletzakis, Antonios6 (AUTHOR), van den Broek, Daan7 (AUTHOR), Bosch, Linda J. W.8 (AUTHOR), Monkhorst, Kim8 (AUTHOR), Smit, Egbert F.1,9 (AUTHOR), de Langen, Adrianus J.1 (AUTHOR) j.d.langen@nki.nl
Source: Cancer (0008543X). Mar2024, Vol. 130 Issue 5, p683-691. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0008543X
DOI:10.1002/cncr.35090